2025 second_quarter Filing

KYOWA KIRIN, INCforUnknown

Expenses

$90K

Method: A

Filed

July 18, 2025

View Original Document

Lobbying Activities

PharmacyView all

FDA modernization policy issues. General issues related to rare disease and clinical trials. General issues related to diagnostics for patients with rare diseases. Issues related to drug pricing. Issues related to reform of pharmacy benefit managers. Issues related to trade. Issues related to Newborn Screening and Genetic Testing.

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Trade (domestic/foreign)View all

Issues related to trade.

Contacted:HOUSE OF REPRESENTATIVES, SENATE

Lobbyists (1)

EDWARD BUCKLEY